G. Rhys Williams, PhD, is affiliated with Sunovion Pharmaceuticals Inc. in Marlborough, Massachusetts. Williams has published research focusing on the economic and fiscal impact of schizophrenia and schizoaffective disorders, including analyses of the lifetime and national economic burdens of these conditions in the United States. Contributions span from 2022 to 2023 in Psychiatrist.com, collaborating frequently with co-authors such as Aditi Kadakia and Annika Anderson.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
